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The goal of the extramural research program of the NIEHS is to fund
the highest-quality science to understand how environmental expo-
sures contribute to the development and progression of human dis-
eases. To identify the most meritorious research proposals, all grant
applications submitted to the NIEHS (as well as to other NIH insti-
tutes and centers) must undergo individual peer review. These
reviews are typically performed by expert committees referred to as
“study sections.” Although some of these reviews take place at the
individual institutes, approximately 70% of all applications are
reviewed at the NIH Center for Scientific Review (CSR). Every year,
CSR study sections review tens of thousands of applications, both
solicited and investigator-initiated, ranging from small research pro-
jects that can be carried out
in a short period of time
with limited resources to
large program projects in
areas as diverse as basic
molecular biology, nursing
research, clinical trials, and
bioengineering. 
Since peer review plays
such a vital role in provid-
ing information for insti-
tutes to use in deciding
which proposals to fund, it
is crucial that the process
ensure the best possible
evaluation of the science.
NIEHS grantees and appli-
cants have raised concerns
over a restructuring at the
CSR that brought about
changes including the
elimination of two study
sections dealing mainly with toxicology. In response, members of
the NIEHS Division of Extramural Research and Training have
embarked on a more formalized and vigorous monitoring and
analysis of outcomes of reviews of NIEHS applications by the CSR.
A number of important observations can now be made as a result
of this evaluation, which is ongoing and expanding. Our initial evalua-
tion suggests that the CSR restructuring does not appear to have had
much of an overall effect on the outcomes of NIEHS applications,
although applications in the oncological sciences are not scoring as well
since the restructuring, and we are trying to determine if this is true in
other topic areas as well. And other problems exist as well. Perhaps the
most significant is that NIEHS applications have had less favorable
review outcomes than applications assigned to most of the other NIH
institutes and centers, in terms of both a larger percentage being
“streamlined” (or identified as having less potential for success and
therefore afforded a less intensive review process) and a smaller per-
centage ranking among the highest-scoring 20% of all applications.  
There are several factors that may contribute to these outcomes.
For instance, the NIEHS has some special characteristics that pre-
sent challenges to the review of our applications. Our broad scien-
tific mission contributes to applications being dispersed over a wide
range of study section topics. We are also relatively small institute.
As a result, on average, fewer applications are reviewed for the
NIEHS per study section than for most other institutes and centers.
Our data indicate that across the NIH, applications from any given
institute generally have less favorable outcomes when reviewed in
study sections in which they represent less than 5% of the total
applications being reviewed. For example, an NIEHS application
may be reviewed in a study section dealing with many aspects of a
particular disease and one that might therefore be dominated by
applications assigned to another institute. In this instance, if the
number of NIEHS applications is small, especially if it represents
less than 5% of the total, it is likely they would not fare as well. This
is true regardless of the institute or center the application is assigned
to, although it can have a greater overall impact on smaller insti-
tutes. Although it is unclear why this trend exists, as more informa-
tion emerges from our evaluation we are confident that its impact
can be minimized.
Achieving the best review process for all applications is a key
part of the mission of the CSR. To this end, senior staff of the CSR
and the NIEHS have had a number of discussions with researchers
from the extramural community about the evaluation process, and
are developing a plan to increase the percentage of NIEHS applica-
tions in any given study section. In addition, we will continue to
work together to monitor and improve the peer-review process for
NIEHS applications across all NIH study sections. The work of the
NIEHS is critical to reducing the burden of disease, improving
human health, and extending survival. An improved peer-review
process will greatly facilitate our ability to identify and fund the best
research to achieve these aims. 
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